<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04286776</url>
  </required_header>
  <id_info>
    <org_study_id>820553</org_study_id>
    <secondary_id>1U01NS113198-01</secondary_id>
    <nct_id>NCT04286776</nct_id>
  </id_info>
  <brief_title>Using Direct Brain Stimulation to Study Cognitive Electrophysiology</brief_title>
  <official_title>Using Direct Brain Stimulation to Study Cognitive Electrophysiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dartmouth College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Freiburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project forms a multi-site research collaboration to carry out verbal and spatial memory
      experiments in patient volunteers to better understand the neural bases of human memory,
      employing direct electrical brain stimulation as a tool to study those dynamics and their
      relationship to memory performance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study protocol outlines fundamental experiments to understand the neural dynamics
      underlying human memory and use direct brain stimulation as a tool (intervention) to study
      the relationship between those dynamics and memory performance. The investigators will
      collect recording and stimulation data from 250 patient volunteers as they perform
      carefully-matched verbal and spatial memory tasks. During non-stimulation sessions, the
      investigators will measure correlative neural biomarkers of memory encoding and retrieval
      using standard clinical depth electrodes and micro-wire recordings. To test the causal role
      of these biomarkers, the investigators will employ direct brain stimulation to briefly
      modulate neural activity, and measure ensuing changes in behavioral performance. With a set
      of causal biomarkers and predictive models in hand, the investigators will finally ask
      whether model-driven stimulation paradigms offer the investigators the ability to reliably
      modulate neural activity, and consequent behavior, in real-time.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 23, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All enrolled patients are considered eligible to receive direct electrical stimulation.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Memory performance</measure>
    <time_frame>Up to 4 weeks (typical duration of hospital stay)</time_frame>
    <description>To measure memory performance, participants will perform a custom episodic memory task (verbal, spatial), with performance compared between sham and stimulation trials to identify if stimulation modulates memory. The primary outcome measure is memory performance, such as the percentage of recalled items.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intracranial electrophysiological recordings: Intracranial Electroencephalogram (iEEG), Spectral Power</measure>
    <time_frame>Up to 4 weeks (typical duration of hospital stay)</time_frame>
    <description>Spectral power will be compared between sham and stimulation trials to identify whether stimulation modulates neuronal biomarkers of memory. Spectral power is measured in microvolts squared.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intracranial electrophysiological recordings: Intracranial Electroencephalogram (iEEG), Synchrony</measure>
    <time_frame>Up to 4 weeks (typical duration of hospital stay)</time_frame>
    <description>Phase and power based synchrony of iEEG data (across or within electrodes) will be compared between sham and stimulation trials to identify whether stimulation modulates neuronal biomarkers of memory. Synchrony can be measured as the length of a resultant vector in complex space and the correlation [-1 to 1] between two time series.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intracranial electrophysiological recordings: Unit Activity, Firing Rate</measure>
    <time_frame>Up to 4 weeks (typical duration of hospital stay)</time_frame>
    <description>Analysis of unit activity data collected on microwire electrodes will be performed, with firing rates compared between sham and stimulation trials to identify if stimulation modulates the inhibitory-excitatory balance as reflected by decreased or increased firing rates. Firing rate is measured in Hz.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intracranial electrophysiological recordings: Unit Activity, Synchrony</measure>
    <time_frame>Up to 4 weeks (typical duration of hospital stay)</time_frame>
    <description>Synchrony of spike trains collected on microwire electrodes will be compared between sham and stimulation trials to identify if stimulation modulates neuronal biomarkers of memory. Synchrony will be measured between different neurons and with the phase of the ongoing local field potential. Synchrony can be measured as the length of a resultant vector in complex space and as the correlation [-1 to 1] between two time series.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Epilepsy Intractable</condition>
  <arm_group>
    <arm_group_label>Direct Electrical Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stimulation will be applied concurrently with the task, if applicable, and stimulation trials will be interleaved with sham trials, where no stimulation is delivered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Direct electrical stimulation</intervention_name>
    <description>Stimulation lasting from 500 to 2000 milliseconds on bipolar target electrode pairs at one of two target frequencies (e.g. 10 Hz and 200 Hz), up to 1.5 milliamperes in amplitude on depth contacts and 3.5 milliamperes in amplitude on surface contacts. (Pulse shape - Charge-balanced biphasic rectangular pulses with pulse width of 300 microseconds in duration per phase).</description>
    <arm_group_label>Direct Electrical Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Subjects will be enrolled who are expected to undergo intracranial electroencephalographic
        monitoring as part of a standard clinical procedure for the treatment of pharmacologically
        resistant epilepsy.

        Exclusion Criteria:

        The following individuals will be excluded:

          -  Any cognitive impairments that would limit their ability to participate in the memory
             testing,

          -  Any physical disability that would limit their ability to perform cognitive tasks
             within normal limits,

          -  Any psychiatric condition that would limit their ability to provide informed consent
             or to perform cognitive tasks within normal limits,

          -  Any medical condition that would, in the investigator's opinion, limit the subject's
             participation in the study,

          -  Who are pregnant,

          -  Unable or unwilling to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kahana, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul Wanda, PhD</last_name>
    <phone>2158988732</phone>
    <email>kahana@psych.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Kahana, PhD</last_name>
    <email>kahana@psych.upenn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03766</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joshua Jacobs, PhD</last_name>
      <email>joshua.jacobs@columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Joshua Jacobs, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Freiburg University Hospital</name>
      <address>
        <city>Freiburg im Breisgau</city>
        <state>Baden-WÃ¼rttemberg</state>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lukas Kunz, PhD</last_name>
      <email>lukas.kunz@uniklinik-freiburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Andreas Schulze-Bonhage, MD</last_name>
      <email>andreas.schulze-bonhage@uniklinik-freiburg.de</email>
    </contact_backup>
    <investigator>
      <last_name>Andreas Schulze-Bonhage, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 24, 2020</study_first_submitted>
  <study_first_submitted_qc>February 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2020</study_first_posted>
  <last_update_submitted>May 7, 2020</last_update_submitted>
  <last_update_submitted_qc>May 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>episodic memory</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified data will be shared in a public repository at regular intervals during the project. De-identified data sets will be anonymized prior to posting on the public repository. These de-identified data are likely to be analyzed for secondary purposes other than those described in this protocol (e.g. seizure prediction). Shared data will include, at a minimum, digital spreadsheets used to summarize all participant behavioral data. De-identified electrophysiology data, demographic information, electrode localization information, and task information (e.g. timing of each trial, timing of responses) will be shared in a central repository. Descriptions of the tasks and stimuli will be shared. De-identified references to individual participant data may also appear in scientific journal publications or presented at scientific meetings.</ipd_description>
    <ipd_time_frame>Study data will become available within six months of publication of the relevant results, with no planned expiration.</ipd_time_frame>
    <ipd_access_criteria>Data is freely available, will require a formal request for access.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

